Radiopharmaceuticals for Neuroendocrine Tumors

Overview of attention for article published in Seminars in Radiation Oncology, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#42 of 500)
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news: 1 news outlet

twitter: 5 X users

Readers on

mendeley: 29 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 5,714 followers.

Seminars in Radiation Oncology will be providing articles from each issue. Today we share another article from the January issue on “Radiopharmaceuticals for Neuroendocrine Tumors “ by Re-I Chin, Francis S. Wu, Yusuf Menda, and Hyun Kim. https://t.co/4E…

RT @adapthyun: Great work by @ReIChinMD on this review paper re: radiopharmaceuticals for NET! @WashURadOnc @SitemanCenter https://t.co/T30…

Nice work by @ReIChinMD, Resident Physician & @adapthyun! #MedEd #RadOnc #TrainHereThriveAnywhere @Sperkins_radonc @AllisonLehman14

RT @adapthyun: Great work by @ReIChinMD on this review paper re: radiopharmaceuticals for NET! @WashURadOnc @SitemanCenter https://t.co/T30…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.